Transparency Notification
THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION.Acacia Pharma Group plc 1. Summary of the notificationCambridge, UK and Indianapolis, US – 05 March 2021, 09:00 CET: Acacia Pharma Group plc has received a transparency notification dated 02 March 2021 indicating that Coltrane Asset Management L.P. now holds, by virtue of the purchase of shares on 18 February 2021, 5.50% of the voting rights of the company. Coltrane has therefore crossed the threshold of 5%.2. Content of notification
The notification dated 2 March 2021 contains the following information:Reason of the notification – acquisition or disposal of voting securities or voting rightsNotification by – a parent undertaking or a controlling personPersons subject to the notification requirement:Date on which the threshold is crossed – 18 February 2021Threshold that is crossed – 5%Denominator – 89,689,451Notified details:
Full chain of controlled undertakings through which the holding is effectively held:Coltrane Asset Management, L.P. is an investment advisor which manages funds and accounts which hold the shares reported in this filing.Coltrane Asset Management, L.P. can exercise the voting rights at its discretion, without any instruction from its clients.Coltrane Asset Management, L.P. is controlled by Coltrane Asset Management Holdings, Ltd, which is controlled by Mandeep Manku. MiscellaneousThis press release is available on Acacia Pharma Group plc’s website (https://acaciapharma.com/investors/regulatory-announcements)